These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13627892)

  • 1. Usefulness of Dunning leukemia IRC741 for quantitative pharmacological studies of cancer chemotherapeutic agents.
    JONES R; McKENZIE D; STEVENS ML; DUNNING WF; CURTIS MR
    Ann N Y Acad Sci; 1958 Dec; 76(3):659-72. PubMed ID: 13627892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cancer chemotherapeutic agents on induction of differentiation of cells and their therapeutic implications].
    Hozumi M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):714-20. PubMed ID: 3457551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
    Hefti E; Blanco JG
    J Pediatr Hematol Oncol; 2016 May; 38(4):283-7. PubMed ID: 26907658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of resistant leukemias in screening for chemotherapeutic activity.
    BURCHENAL JH; HOLMBERG EA
    Ann N Y Acad Sci; 1958 Dec; 76(3):826-31; discussion 832-7. PubMed ID: 13627910
    [No Abstract]   [Full Text] [Related]  

  • 5. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical experience with thio-TEPA in leukemia and inoperable cancer.
    SHAY H; SUN DC
    Ann N Y Acad Sci; 1958 Apr; 68(3):1046-56. PubMed ID: 13627754
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Koppan M; Nagy A; Schally AV; Arencibia JM; Plonowski A; Halmos G
    Cancer Res; 1998 Sep; 58(18):4132-7. PubMed ID: 9751625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents.
    Trendowski M; Wong V; Yu G; Fondy TP
    Anticancer Res; 2015 Jan; 35(1):65-76. PubMed ID: 25550536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
    Dührsen U
    Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells.
    Büyükavci M; Ozdemir O; Buck S; Ravindranath Y; Savaşan S
    In Vivo; 2011; 25(3):405-9. PubMed ID: 21576415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic experiments with the Shay leukemia.
    NEMETH L
    Neoplasma; 1963; 10():31-4. PubMed ID: 13938091
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced leukemia as a tool for chemotherapeutic studies.
    GOLDIN A; VEDITTI JM; HUMPHREYS SR; SHUSTER L; DARROW RA; MANTEL N
    Acta Unio Int Contra Cancrum; 1960; 16():642-50. PubMed ID: 13850661
    [No Abstract]   [Full Text] [Related]  

  • 14. THE USE OF CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF CHILDHOOD CANCER.
    DARBY CP
    J S C Med Assoc; 1964 Apr; 60():97-100. PubMed ID: 14138401
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of selected cancer chemotherapeutic drugs on the survival times of mice with L-1210 leukemia: relative responses of antimetabolite resistant strains.
    HUTCHISON DJ; ROBINSON DL; MARTIND ; ITTENSOHN OL; DILLENBERG J
    Cancer Res; 1962 Jan; 22(1)Pt 2():57-72. PubMed ID: 14450250
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural and Synthetic Flavonoids: Structure-Activity Relationship and Chemotherapeutic Potential for the Treatment of Leukemia.
    Menezes JC; Orlikova B; Morceau F; Diederich M
    Crit Rev Food Sci Nutr; 2016 Jul; 56 Suppl 1():S4-S28. PubMed ID: 26463658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of chemotherapeutic management of chronic granulocytic and chronic lymphocytic leukemia.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1960 Apr; 132():145-50. PubMed ID: 14441243
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapeutic control of acute leukemia. III, Miscellaneous agents.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1961 Nov; 133():395-400. PubMed ID: 14496652
    [No Abstract]   [Full Text] [Related]  

  • 19. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of the various morphologic types of childhood leukemia and their response to certain chemotherapeutic agents.
    CARTER RE; BRUBAKER CA; LEIKIN SL; LOUIS J; SEVERO N; WOLFF JA
    Cancer Chemother Rep; 1962 Feb; 16():155-6. PubMed ID: 13876967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.